Skip to main content

Day: January 11, 2024

Eye Melanoma Market Size Worth USD 9.56 Billion in 2032 | Emergen Research

Eye melanoma market revenue growth can be attributed to increasing prevalence of eye cancer across the globe, numerous Research & Development (R&D) activities by market players, and rising demand for minimally invasive treatment procedures for treatment of eye cancers Vancouver, Jan. 11, 2024 (GLOBE NEWSWIRE) — The global eye melanoma market size was USD 4.35 billion in 2022 and is expected to register a revenue CAGR of 8.3% during the forecast period. Eye melanoma market revenue growth can be attributed to increasing prevalence of eye cancer across the globe, numerous Research & Development (R&D) activities by market players, and rising demand for minimally invasive treatment procedures for treatment of eye cancers. Medical technology is shaping the future of ophthalmology industry, which includes significant...

Continue reading

Ruthenium Market Size Worth USD 888.5 Million in 2032 | Emergen Research

Rising product demand from the electronics industry due to customer preferences, growing adoption of ruthenium as a catalyst, and in electrochemical sector, and increasing product of medical devices Vancouver, Jan. 11, 2024 (GLOBE NEWSWIRE) — The global ruthenium market size was USD 572.4 Million in 2022 and is expected to register a revenue CAGR of 4.7% during the forecast period. Rising product demand from the electronics industry due to customer preferences, growing adoption of ruthenium as a catalyst, and in electrochemical sector, and increasing product of medical devices such as Magnetic Resonance Imaging (MRI) imaging devices are expected to drive revenue growth of the market. Ruthenium refers to a chemical element that is one of the rarest metals on Earth. Ruthenium is being extensively used in various high-tech industries...

Continue reading

Sodium Caseinate Market Size Worth USD 7.70 Billion in 2032 | Emergen Research

Rising product demand from the food and beverage industry, growing adoption of ready-to-drink beverages and protein enriched drinks, rising consumer awareness in health and wellness Vancouver, Jan. 11, 2024 (GLOBE NEWSWIRE) — The global sodium caseinate market size was USD 5.09 Billion in 2022 and is expected to register a revenue CAGR of 4.4% during the forecast period. Rising product demand from the food and beverage industry, growing adoption of ready-to-drink beverages and protein enriched drinks, rising consumer awareness in health and wellness and rising demand for cosmetics and personal care products are expected to drive revenue growth of the market. Sodium caseinate is being extensively used in various high-tech industries and specialized applications such as food and beverage, pharmaceuticals, cosmetics, chemicals, and...

Continue reading

Terephthalic Acid Market Size Worth USD 90.25 Billion in 2032 | Emergen Research

Rising demand for polyesters in textile and packaging industries, growing adoption of terephthalic acid in textile and home furnishing sector Vancouver, Jan. 11, 2024 (GLOBE NEWSWIRE) — The global terephthalic acid market size was USD 56.48 Billion in 2022 and is expected to register a revenue CAGR of 4.9% during the forecast period. Rising demand for polyesters in textile and packaging industries, growing adoption of terephthalic acid in textile and home furnishing sector, rising global demand for Polyethylene Terephthalate (PET) resin from packaging materials, and increasing adoption of PET film as a protective layer in building materials are expected to drive market revenue growth. Terephthalic acid refers to a carboxylic acid which is a very versatile and widely used monomer in almost all industrial polymers. Terephthalic acid...

Continue reading

Olympic Surfer Caroline Marks to Ride Wave of Support From Grom Social as Premiere App for Kids Cheers its Original Ambassador on to the Paris 2024 Games!

Marks Returns to US Women’s Olympic Surfing Team as Americans Look to Make Waves at French Polynesia During Summer Olympics BOCA RATON, Fla., Jan. 11, 2024 (GLOBE NEWSWIRE) — 2023 World-class champion surfer, and 2024 Paris Olympic hopeful, Caroline Marks, will get the gold medal treatment from Grom Social, the premier social media app for kids, as she mounts her surfboard on her journey in her quest for a gold medal. In the weeks leading up to the competition, Marks, who also competed at the Tokyo Summer Olympics, will be featured in short-form content on Grom as she chronicles her journey to the games, shares tips on digital safety and discusses her approach to personal physical wellness. The in-app content, which will be featured alongside a host of new updates coming to Grom Social this spring, was announced today by her brother,...

Continue reading

e-clinical solutions market Size Worth USD 30.75 Billion in 2032 | Emergen Research

Steady e-clinical solutions market revenue growth can be attributed to increasing number of chronic cases across the globe, rising demand of novel software solutions by pharma and biotech companies and growing supportive initiatives by governments for clinical trials Vancouver, Jan. 11, 2024 (GLOBE NEWSWIRE) — The global e-clinical solutions market size was USD 8.82 billion in 2022 and is expected to register a revenue CAGR of 13.5% during the forecast period. Steady market revenue growth can be attributed to increasing number of chronic cases across the globe, rising demand of novel software solutions by pharma and biotech companies, growing need for consistent and standardized data across clinical trials, and growing supportive initiatives by governments for clinical trials worldwide. eClinical solutions is developed for monitoring...

Continue reading

A Record Revenue Year for Maris-Tech.

Preliminary 2023 Gross Revenues Expected to Be Approximately $4,000,000 Driven by robust demand for the Company’s defense and AI-powered solutions, gross revenues increased by approximately 60% compared to the previous year Rehovot, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK) (“Maris-Tech” or the “Company”), a B2B provider of edge computing artificial intelligence (AI) accelerated video solutions for edge platforms, today announced preliminary and partial results for 2023. The Company expects that its gross revenues for the year ended December 31, 2023 will be approximately $4,000,000, which is in the upper range of the previously announced revenue forecast of between $3,700,000 and $4,200,000, and if achieved would reflect an increase of approximately 60% over the Company’s...

Continue reading

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

BERKELEY, Calif. and MAINZ, Germany, Jan. 11, 2024 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in early cancer detection, re-affirms its collaboration with TestDNA at the upcoming 10th Gdańsk Gastroenterology Symposium on January 12th–13th, 2024. The companies joined forces to advance innovative colorectal cancer (CRC) detection in Poland and to increase treatment options as well as survival rates through early detection. The 10th Gdańsk Gastroenterology Symposium gathers national Polish lecturers, scientists, and practitioners who will share the latest insights in gastroenterology, hepatology, and gastrointestinal endoscopy. Mainz Biomed and TestDNA will be present as exhibitor during the two day symposium, they will also open the second...

Continue reading

AEG and Vivid Seats Announce LA Kings and LA Galaxy Partnership

AEG and Vivid Seats Announce LA Kings PartnershipAEG and Vivid Seats Announce LA Kings PartnershipCHICAGO, Jan. 11, 2024 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, and AEG, the world’s leading sports and live entertainment company, have launched a new partnership that makes Vivid Seats an official secondary ticketing marketplace partner of the LA Kings (NHL) and the LA Galaxy (MLS). As part of the agreement, brokered by AEG Global Partnerships, Vivid Seats will enable fans of both teams to purchase tickets to all regular season home games on Vivid Seats’ platform. This announcement marks Vivid Seats’ first partnership with an NHL team, and...

Continue reading

Allegro MicroSystems to Announce Third Quarter Fiscal Year 2024 Financial Results

MANCHESTER, N.H., Jan. 11, 2024 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced it plans to release financial results for its third quarter fiscal year 2024 prior to the market open on Thursday, February 1, 2024. Following the press release, Vineet Nargolwala, President and Chief Executive Officer, and Derek D’Antilio, Senior Vice President and Chief Financial Officer, will host a conference call at 8:30 a.m. Eastern Time to discuss the Company’s results and business outlook. Analysts and investors are invited to join the conference call using the following information: Third Quarter Fiscal Year 2024 Earnings Conference CallDate: Thursday, February 1, 2024Time: 8:30 a.m. EDTLive Webcast Link: Click HereDial-in Participant Registration Link: Click Here Advanced registration is required for dial-in participants....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.